Abridge
Abridge provides an AI-native clinician intelligence platform that documents patient-clinician conversations and uses them as the foundation for billing, clinical decision support, payer adjudication, and pharmaceutical trial screening.
Raised $830M across disclosed rounds.[3]
Series E closed June 2025, led by Andreessen Horowitz.[1][2][5][14]
post-money valuation is not publicly disclosed.
Named investors include Andreessen Horowitz, Khosla Ventures, Elad Gil, IVP, Bessemer Venture Partners, California Health Care Foundation, CapitalG, CVS Health Ventures, K. Ventures, Lightspeed Venture Partners, NVentures, Redpoint Ventures, Spark Capital, SV Angel, Eli Lilly.[1][2][3][5][6][14]
Shiv Rao, CEO and Co-Founder[1][31]
Mario Queiroz, Chief Product Officer[2][15][16][17][18][19][31]
Yan Yang, Head of Data[2][15][16][17][18][19][31]
Laurel Parker, Vice President of Operations[2][15][16][17][18][19][31]
Rez Khan, Staff, Product Management Team[2][15][16][17][18][19][31]
Daniel Gloede, Vice President, Finance Operations[2][15][16][17][18][19][31]
Zack Lipton, Chief Technology Officer[2][15][16][17][18][19][31]
Julia Chou, Chief Operating Officer[2][15][16][17][18][19][31]
Nabla · nabla.com · Same job to be done: AI-powered medical note-taking for doctors.[14]
CodaMetrix · codametrix.com · Same workflow: AI-driven medical coding, which Abridge is expanding into.[1][14]
Regard · regard.ai · Same job to be done: AI-powered physician note-taking.[14]
Freed AI · freed.ai · Same job to be done: AI clinician assistant for documentation.[14]
The customer proof is company-sourced only. No independent source in this ledger confirms it.[7]
Ask for one referenceable production customer.
Not a recommendation. The first thing this ledger cannot answer.
Filled in the side panel for invited readers. This card carries sourced facts only.
Edition 3Oct 6 2026current
Since edition 2
- Raised $758M to $830M
- Headcount 673 to 676
- New person Laurel Parker, Vice President of Operations
- New person Daniel Gloede, Vice President, Finance Operations
- New person Zack Lipton, Chief Technology Officer
- New person Julia Chou, Chief Operating Officer
- No longer listed Priya Brandes, Assistant General Counsel, Corporate
- No longer listed Tony Burian, Sr. Engineering Manager, Platform
- Newly listed Abridge September 2026 Release: Inpatient Cues, New Specialty Support, & More · Sep 2026
- Newly listed WashU Medicine and BJC Health Expand Abridge to 4,000 Clinicians · Feb 2026
- Sources 32 → 31 (9 new, 10 not used)
Edition 2Oct 1 2026
Since edition 1
- Headcount 408 to 673
- New person Mario Queiroz, Chief Product Officer
- New person Yan Yang, Head of Data
- New person Priya Brandes, Assistant General Counsel, Corporate
- New person Tony Burian, Sr. Engineering Manager, Platform
- No longer listed Brian Wilson, Chief Commercial Officer (CCO)
- No longer listed Reid F. C., Sr. Physician Executive
- No longer listed San Oo, CTO
- New signal Abridge Selected for VA Ambient AI Enterprise Contract · Sep 2026
- New signal Abridge Extends Intelligence to CDI and Coding Teams, Reviewing Inpatient Claims Before They’re Submitted · Sep 2026
- New signal Abridge Makes Context-Aware Clinical Intelligence Available to Every Clinician at Partner Health Systems · Aug 2026
- New signal WashU Medicine and BJC Health Expand Abridge to 4,000 Clinicians · Jul 2026
- New signal CHRISTUS Health Expanded with Trusted AI Partner Abridge · Jul 2026
- Newly listed UCHealth Rapidly Expands Abridge AI Across 2,300+ Providers · Feb 2026
- Sources 16 → 32 (17 new, 2 not used)
- Edition 1Jun 23 2026Earliest saved edition
Oct 2026 · techcrunch.com
reported
Oct 2026 · fiercehealthcare.com
reported
Oct 2026 · fortune.com
reported
Oct 2026 · abridge.com
company
Oct 2026 · abridge.com
company
Oct 2026 · news.crunchbase.com
reported
Jun 2026 · prospectoo.com
reported
Jun 2026 · signalhire.com
vendor
Abridge
Abridge provides an AI-native clinician intelligence platform that documents patient-clinician conversations and uses them as the foundation for billing, clinical decision support, payer adjudication, and pharmaceutical trial screening.
Ask for one referenceable production customer.
Not a recommendation. The first thing this ledger cannot answer.